About the Authors
- Daryl L. Richie
-
Affiliation Novartis Institutes for BioMedical Research, Emeryville, CA, United States of America
- Kenneth T. Takeoka
-
Affiliation Novartis Institutes for BioMedical Research, Emeryville, CA, United States of America
- Jade Bojkovic
-
Affiliation Novartis Institutes for BioMedical Research, Emeryville, CA, United States of America
- Louis E. Metzger IV
-
Affiliation Novartis Institutes for BioMedical Research, Emeryville, CA, United States of America
- Christopher M. Rath
-
Affiliation Novartis Institutes for BioMedical Research, Emeryville, CA, United States of America
- William S. Sawyer
-
Affiliation Novartis Institutes for BioMedical Research, Emeryville, CA, United States of America
- Jun-Rong Wei
-
Affiliation Novartis Institutes for BioMedical Research, Emeryville, CA, United States of America
- Charles R. Dean
-
* E-mail: charlesr.dean@novartis.com
Affiliation Novartis Institutes for BioMedical Research, Emeryville, CA, United States of America
Competing Interests
The authors are, at present, or were during the time of their contribution to this manuscript, employed by Novartis. As such, the authors may own stock in Novartis as part of their remuneration for employment. The authors have no competing interests as regards consultancies, patents or products in development or currently marketed. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceptualization: DLR CRD. Data curation: JB CMR WSS. Formal analysis: DLR JB CMR WSS. Investigation: DLR KTT CRM JB WSS LEMIV. Methodology: CMR JB LEMIV WSS JRW KTT DLR CRD. Project administration: CRD DLR CMR. Supervision: CRD DLR CMR JRW. Validation: DLR KTT CMR LEMIV JB. Visualization: DLR CMR JB WSS LEMIV JRW. Writing - original draft: DLR CRD. Writing - review & editing: DLR CRD CMR LEMIV JRW.